TISSUE ENGINEERING: Part B, 2019 · DOI: 10.1089/ten.teb.2019.0182 · Published: October 23, 2019
Spinal cord injury is a serious condition lacking effective regenerative treatments. Recent advances in stem cell technology, biomaterials, nanotechnology, and immune engineering offer potential regenerative therapies. Combinatorial therapies leveraging multiple approaches may be necessary for satisfactory outcomes. The review focuses on minimally invasive therapies designed to promote neuroregeneration and neuroprotection after SCI. It discusses previously explored therapies, highlighting present challenges and future directions in the field. Future successful approaches for the treatment of SCI will likely include the integration of several recent advances in various fields as combinatorial therapies in minimally invasive formats.
Clinical translation of regenerative therapies for SCI will be facilitated by the use of minimally invasive strategies to reduce complications and spare neuronal circuitry.
Combinatorial therapies that simultaneously leverage multiple approaches are likely required to achieve satisfactory outcomes in SCI treatment.
Future research should focus on integrating recent advances in stem cell technology, biomaterials, nanotechnology, and immune engineering to develop effective combinatorial therapies.